Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Thomas H Rude
Affiliation
Duke University Medical Center, Medical Center
ORCID
Career Start Year
1976
Papers
40
H Index
28
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
25682374
Pulse Field Gel Electrophoresis.
Methods Mol Biol
2016
25392350
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
J Clin Microbiol
2015
26606522
Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty Infection.
PLoS One
2015
26416903
Endovascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the occurrence of fnbB.
Infect Immun
2015
26213692
Potential Influence of Staphylococcus aureus Clonal Complex 30 Genotype and Transcriptome on Hematogenous Infections.
Open Forum Infect Dis
2015
24524581
A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting.
BMC Infect Dis
2014
25734164
Whole Genome Sequencing of a Methicillin-Resistant Staphylococcus aureus Pseudo-Outbreak in a Professional Football Team.
Open Forum Infect Dis
2014
24879783
Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections.
Clin Infect Dis
2014
23599317
Virulence of endemic nonpigmented northern Australian Staphylococcus aureus clone (clonal complex 75, S. argenteus) is not augmented by staphyloxanthin.
J Infect Dis
2013
22205797
Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus.
J Clin Microbiol
2012
22623995
Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.
PLoS One
2012
21541311
Potential associations between severity of infection and the presence of virulence-associated genes in clinical strains of Staphylococcus aureus.
PLoS One
2011
21844296
Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins.
J Infect Dis
2011
20211890
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
Antimicrob Agents Chemother
2010
20824097
Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses.
PLoS Pathog
2010
19487449
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
Antimicrob Agents Chemother
2009
19846653
Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial.
J Clin Microbiol
2009
19811099
Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.
J Infect Dis
2009
18077636
Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections.
J Clin Microbiol
2008
18596141
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients.
J Clin Microbiol
2008
17698629
Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target.
Antimicrob Agents Chemother
2007
17674317
Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection.
J Infect Dis
2007
16988267
Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans.
Infect Immun
2006
12686646
Regulation of cytochrome c oxidase subunit 1 (COX1) expression in Cryptococcus neoformans by temperature and host environment.
Microbiology (Reading)
2003
12228298
Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans.
Infect Immun
2002
9882657
A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function.
J Bacteriol
1999
10224251
Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target.
Genetics
1999
10085022
Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein.
Infect Immun
1999
8752346
Identification of a Cryptococcus neoformans gene that directs expression of the cryptic Saccharomyces cerevisiae mannitol dehydrogenase gene.
J Bacteriol
1996
8531025
The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis.
J Med Vet Mycol
1995
8406836
The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.
Infect Immun
1993
8444802
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA.
J Bacteriol
1993
1452032
Cloning the Cryptococcus neoformans TRP1 gene by complementation in Saccharomyces cerevisiae.
Gene
1992
6873192
Fractionation and characterization of DNA at sites of replication from rat liver nuclei.
Exp Cell Res
1983
7307005
Lung cancer model system using 3-methylcholanthrene in inbred strains of mice.
Cancer Res
1981
6766516
Carcinogenicity of benzo[a]pyrene and thirteen of its derivatives in C3H/fCum mice.
J Natl Cancer Inst
1980
7397681
Correlation of inducibility of aryl hydrocarbon hydroxylase with susceptibility to 3-methylcholanthrene-induced lung cancers.
Cancer Lett
1980
510243
Biological activity of tobacco smoke and tobacco smoke-related chemicals.
Environ Health Perspect
1979
679184
2,3,7,8-tetrachlorodibenzo-p-dioxin as cocarcinogen causing 3-methylcholanthrene-initiated subcutaneous tumors in mice genetically "nonresponsive" at Ah locus.
Cancer Res
1978
1269048
Studies on pulmonary aryl hydrocarbon hydroxylase activity in inbred strains of mice.
Chem Biol Interact
1976
1 - 40 of 40
Column Actions
Search
Recommended Authors
Scott D Pope
Yale School of Medicine, USA Howard Hughes Medical Institute
Career Start Year
2005
Number of shared co-authors
0
Ian McHardy
University of California, Davis Center for Valley Fever
Career Start Year
2005
Number of shared co-authors
0
Michael A Fischbach
Stanford University
Career Start Year
2003
Number of shared co-authors
0
John A McCulloch
Center for Cancer Research, National Cancer Institute
Career Start Year
2003
Number of shared co-authors
0
Marcia Regina von Zeska Kress
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo (USP)
Career Start Year
2001
Number of shared co-authors
0
Fernanda P Silveira
Federal University of Rio de Janeiro
Career Start Year
1998
Number of shared co-authors
1
Nathalie Tijet
University Avenue
Career Start Year
1998
Number of shared co-authors
0
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Career Start Year
1997
Number of shared co-authors
0
Craig Daniels
The Hospital for Sick Children
Career Start Year
1997
Number of shared co-authors
0
Deborah A Hogan
Geisel School of Medicine at Dartmouth
Career Start Year
1997
Number of shared co-authors
0
Hyeseung Lee
Picower Institute for Learning and Memory, Massachusetts Institute of Technology
Career Start Year
1996
Number of shared co-authors
0
Yolanda Gil
Hospital Universitario de Mostoles C/Dr. Luis Montes
Career Start Year
1995
Number of shared co-authors
0
James R Brown
GlaxoSmithKline Pharma R&D, 1250 S. Collegeville Rd, Collegeville
Career Start Year
1994
Number of shared co-authors
0
Minh Thu Nguyen
Institute of Medical Microbiology, University Hospital of Munster
Career Start Year
1993
Number of shared co-authors
0
Paul D Fey
University of Nebraska Medical Center
Career Start Year
1993
Number of shared co-authors
1
Roger E Bumgarner
University of Washington
Career Start Year
1992
Number of shared co-authors
0
Victor Nizet
university of california san diego School of Medicine
Career Start Year
1991
Number of shared co-authors
0
Istv??n Nagy
Institute of Biochemistry, HUN-REN Biological Research Centre
Career Start Year
1991
Number of shared co-authors
0
Martha Flores
Centro Hospitalar do Baixo Vouga
Career Start Year
1990
Number of shared co-authors
0
Mark D Adams
Case Western Reserve University School of Medicine
Career Start Year
1989
Number of shared co-authors
1
Christophe d'Enfert
Institut Pasteur, Universite Paris Cite
Career Start Year
1985
Number of shared co-authors
0
Bruce W Birren
Broad Institute of MIT and Harvard
Career Start Year
1983
Number of shared co-authors
1
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Career Start Year
1982
Number of shared co-authors
1
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Career Start Year
1981
Number of shared co-authors
0
Michael S Gilmore
Harvard Medical School, USA Infectious Disease Institute (P.J.M.B.
Career Start Year
1981
Number of shared co-authors
0
George M Weinstock
The Genome Center at Washington University, Washington University School of Medicine
Career Start Year
1979
Number of shared co-authors
1
Gregory A Buck
Virginia Commonwealth University.
Career Start Year
1978
Number of shared co-authors
0
Jerold E Rehg
St. Jude Children's Research Hospital
Career Start Year
1975
Number of shared co-authors
0
Erica Sodergren
The Genome Institute at Washington University
Career Start Year
1972
Number of shared co-authors
1
David C Hooper
Massachusetts General Hospital
Career Start Year
1962
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Vance G Fowler
Duke University School of Medicine
Co-authored papers
21
Batu K Sharma-Kuinkel
Duke University Medical Center
Co-authored papers
11
Felicia Ruffin
Duke University School of Medicine
Co-authored papers
6
Charlotte L Nelson
Duke Clinical Research Institute
Co-authored papers
5
Sun-Hee Ahn
The Warren Alpert Medical School of Brown University/Rhode Island Hospital
Co-authored papers
5
Yurong Zhang
Wuhan University of Technology
Co-authored papers
3
Lindsay G Cowell
University of Texas Southwestern Medical Center
Co-authored papers
2
William K Scott
John P. Hussman Institute for Human Genomics.
Co-authored papers
2
Amy Y Tong
University of Michigan, Duke University Eye Center
Co-authored papers
2
Kimberly Pelak
Foundation Medicine
Co-authored papers
1
Andrew S Allen
Duke University School of Medicine
Co-authored papers
1
Claire M Fraser
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers
1
Mihai V Podgoreanu
Duke University
Co-authored papers
1
Daniel W Nebert
Co-authored papers
1
1 - 14